- Home
- ZTS
ZTS
Zoetis Inc.
as 01-17-2025 4:00pm EST
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
| Founded: | 1952 | Country: | United States |
| Employees: | N/A | City: | PARSIPPANY |
| Market Cap: | 80.4B | IPO Year: | 2013 |
| Target Price: | $215.38 | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.32 | EPS Growth: | 8.38 |
| 52 Week Low/High: | $144.80 - $200.53 | Next Earning Date: | 02-13-2025 |
| Revenue: | $9,152,000,000 | Revenue Growth: | 9.33% |
| Revenue Growth (this year): | 9.48% | Revenue Growth (next year): | 4.87% |
Stock Insider Trading Activity of Zoetis Inc. (ZTS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Polzer Robert J | ZTS | Executive Vice President | Nov 25 '24 | Sell | $177.46 | 3,477 | $617,028.42 | 3,249 |
Latest Zoetis Inc. News
ZTS Breaking Stock News: Dive into ZTS Ticker-Specific Updates for Smart Investing
Motley Fool
4 days ago
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
MT Newswires
5 days ago
Leerink Partners Adjusts Zoetis Price Target to $205 From $215, Maintains Outperform Rating
Bloomberg
7 days ago
Zoetis CEO Says Its Arthritis Drug for Dogs Is Safe
Simply Wall St.
11 days ago
Investors in Zoetis (NYSE:ZTS) have unfortunately lost 18% over the last three years
Zacks
11 days ago
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Zacks
12 days ago
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
PR Newswire
14 days ago
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?
MT Newswires
14 days ago
Stifel Adjusts Zoetis' Price Target to $180 From $210, Keeps Buy Rating
Compare ZTS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZTS Zoetis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.